← Back to Clinical Trials
Recruiting NCT07317947

NCT07317947 Lateral Crural Steal With Columellar Strut Graft in Primary Open Rhinoplasty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07317947
Status Recruiting
Phase
Sponsor Kafrelsheikh University
Condition Rhinoplasty
Study Type INTERVENTIONAL
Enrollment 22 participants
Start Date 2026-01-05
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Lateral crural steal with columellar strut graft in Primary Open Rhinoplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 22 participants in total. It began in 2026-01-05 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to assess the effect of Lateral crural steal with Columellar strut graft done in Primary Open Rhinoplasty and its long-term sustainability on nasal tip projection and nasal tip rotation.

Eligibility Criteria

Inclusion Criteria: * Patients seeking primary rhinoplasty for aesthetic and/or functional indications. * Presence of inadequate nasal tip projection and/or rotation suitable for correction using lateral crural steal with columellar strut graft. * Ability to provide written informed consent and comply with follow-up visits. Exclusion Criteria: * History of prior nasal surgery. * History of severe nasal trauma, altering cartilage architecture. * Significant functional nasal obstruction requiring complex external nasal valve reconstruction. * Patients with excessively wide alar base requiring alar base reduction involving vestibular sill excision (to prevent confounding on projection/rotation). * Patients with facial skeletal or developmental abnormalities e.g. maxillary hypoplasia, maxillary prognathism, dentofacial deformities. * Patients with psychiatric illness or Body Dysmorphic Disorder. * Significant medical comorbidities contraindicating elective surgery or general anesthesia. * Inability to provide informed consent or comply with follow-up.

Contact & Investigator

Central Contact

Ahmed Elsaeed Habib

✉ aelsaeid11@gmail.com

📞 +201094661161

Principal Investigator

Safwat Adel Hegazy

STUDY DIRECTOR

Kafrelsheikh University

Frequently Asked Questions

Who can join the NCT07317947 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Rhinoplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07317947 currently recruiting?

Yes, NCT07317947 is actively recruiting participants. Contact the research team at aelsaeid11@gmail.com for enrollment information.

Where is the NCT07317947 trial being conducted?

This trial is being conducted at Kafr ash Shaykh, Egypt.

Who is sponsoring the NCT07317947 clinical trial?

NCT07317947 is sponsored by Kafrelsheikh University. The principal investigator is Safwat Adel Hegazy at Kafrelsheikh University. The trial plans to enroll 22 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology